KING OF PRUSSIA, Pa., June 15, 2016 /PRNewswire/ -- Greenphire, the global leader in clinical payment solutions,
According to the U.S. National Institutes of Health (NIH), nearly 60 percent of the clinical trials being conducted today include sites outside of the U.S., a number that has increased more than five-fold since 2004.
"Engaging and retaining patients in clinical research is challenging, regardless of where the trial is located," said Jim Murphy, CEO of Greenphire. "Expanding ClinCard's capabilities provides a simplified, proven solution that meets market-specific requirements and reduces the burden of global clinical trial execution."
With this expansion, the ClinCard solution will reimburse global clinical trial participants via a reloadable debit card in their local currency, simplifying both the site and patient clinical trial experience through improved retention, engagement and overall operational efficiencies.
ClinCard provides comprehensive control and visibility into patient reimbursements, critical for global studies. With the expansion, global trials gain financial transparency and consistency, further supporting compliance and reporting requirements.
Greenphire will be exhibiting at booth 2317 at the 52nd annual DIA conference taking place from June 26-30 in Philadelphia. Schedule a meeting with Greenphire to learn more about ClinCard's expanded global capabilities.
About Greenphire Greenphire is the leader in global clinical trial payment solutions. Greenphire's best-in-class solutions optimize clinical trial performance by simplifying and streamlining payment processes from sponsors and CROs to sites and patients. Greenphire's ClinCard and eClinicalGPS solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.
Media Contact:Kathleen Fusco(267) [email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/greenphire-enhances-clincards-ability-to-support-patient-engagement-and-retention-for-global-clinical-trials-300284224.html
Subscribe to our Free Newsletters!
Breathing in unclean air due to increasing air pollution could cause kidney damage with resultant ...
Benign prostatic hyperplasia or enlarged prostate is a noncancerous condition observed in men above ...
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...View All